WO2026033009 - PHYTOLOGICAL COMPOSITION FOR THE TREATMENT OF SKIN CANCER
National phase entry is expected:
Publication Number
WO/2026/033009
Publication Date
12.02.2026
International Application No.
PCT/EP2025/072573
International Filing Date
06.08.2025
Title **
[English]
PHYTOLOGICAL COMPOSITION FOR THE TREATMENT OF SKIN CANCER
[French]
COMPOSITION PHYTOLOGIQUE POUR LE TRAITEMENT DU CANCER DE LA PEAU
Applicants **
BOGONI, Sebastiano Stefano Giuseppe
PHYTOHEAL MEDTECH INTERNATIONAL
Inventors
POLIMENO, Tiziana Rosa Natalina
Priority Data
102024000018583
07.08.2024
IT
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2110 | |
| EPO | Filing, Examination, Granting | 9687 | |
| Japan | Filing, Examination, Granting | 2262 | |
| South Korea | Filing, Examination, Granting | 2236 | |
| USA | Filing, Examination, Granting | 12540 |
Total:
28,835
Contact Us
Abstract[English]
. The present invention also relates to pharmaceutical formulations comprising the phytological composition and suitable pharmaceutically acceptable excipients.[French]
. La présente invention concerne également des formulations pharmaceutiques comprenant la composition phytologique et des excipients pharmaceutiquement acceptables appropriés.